BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies deals with advanced medical devices, medication, diagnostics, and digital healthcare. BioLight's portfolio includes: DiagnosTear's TeaRx, LipiCare, ViSci, OphRx, Peripherex, AEYE, Tarsier, Belkin Vision, and Sanoculis. The company was founded on April 20, 2005 and is headquartered in Tel Aviv, Israel.